When wildfires draped smoke over New York this summer, nearly half of its counties lacked data on air quality. Cornell has led an effort to install sensors in places where there were none.
A team of faculty members and researchers, led by Gen Meredith from the College of Veterinary Medicine’s Department of Public and Ecosystem Health, has partnered with eCornell to launch the Public Health Essentials online certificate program.
An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
An international phase 3 clinical trial found that a new targeted treatment, given in combination with a standard chemotherapy, extended survival for select patients with advanced gastric or gastroesophageal junction cancer.
Pfizer and BioNTech have begun a clinical trial for an Omicron-specific Covid-19 vaccine candidate. But Dr. Luis Schang, a virologist at Cornell University, says while it makes sense to develop a specific vaccine against Omicron, we should not lose sight of what is already available.
The hackathons, run by Entrepreneurship at Cornell, are open to undergraduate and graduate students from any field and major and take place from Friday evenings through Sunday afternoon.
A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.
Eight projects have been selected from the Fall 2023 application cycle to receive Ignite Innovation Acceleration grants. The grants are designed to help project teams pursue licensing, form startups, and forge industry collaborations.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.
